Your browser doesn't support javascript.
loading
Association between serum potassium, risk and prognosis of peritonitis in peritoneal dialysis patients - results from the Peritoneal Dialysis Telemedicine-assisted Platform Cohort (PDTAP) Study.
Wang, Zi; Ma, Xiaoying; Li, Shaomei; Pei, Huaying; Zhao, Jinghong; Zhang, Ying; Xiong, Zibo; Liao, Yumei; Li, Ying; Lin, Qiongzhen; Hu, Wenbo; Li, Yulin; Zheng, Zhaoxia; Duan, Liping; Fu, Gang; Guo, Shanshan; Zhang, Beiru; Yu, Rui; Hao, Li; Liu, Guiling; Zhao, Zhanzheng; Xiao, Jing; Shen, Yulan; Zhang, Yong; Du, Xuanyi; Ji, Tianrong; Wang, Caili; Deng, Lirong; Yue, Yingli; Chen, Shanshan; Ma, Zhigang; Li, Yingping; Zuo, Li; Zhao, Huiping; Zhang, Xianchao; Wang, Xuejian; Liu, Yirong; Gao, Xinying; Chen, Xiaoli; Li, Hongyi; Du, Shutong; Zhao, Cui; Xu, Zhonggao; Zhang, Li; Chen, Hongyu; Li, Li; Wang, Lihua; Yan, Yan; Ma, Yingchun; Wei, Yuanyuan.
Affiliation
  • Wang Z; Renal Division, Department of Medicine, Peking University First Hospital, Beijing, China.
  • Ma X; Institute of Nephrology, Peking University, Beijing, China.
  • Li S; Key Laboratory of Renal Disease, Ministry of Health, Beijing, China.
  • Pei H; Key Laboratory of Renal Disease, Ministry of Education, Beijing, China.
  • Zhao J; Renal Division, Department of Medicine, Cangzhou Central Hospital, Cangzhou, Hebei, China.
  • Zhang Y; Renal Division, Department of Medicine, The Second Hospital of Hebei Medical University, Shijiazhuang, Hebei, China.
  • Xiong Z; Renal Division, Department of Medicine, The Second Hospital of Hebei Medical University, Shijiazhuang, Hebei, China.
  • Liao Y; Department of Nephrology, The Key Laboratory for the Prevention and Treatment of Chronic Kidney Disease of Chongqing, Chongqing Clinical Research Center of Kidney and Urology Diseases, Xinqiao Hospital, Army Medical University (Third Military Medical University), Chongqing, China.
  • Li Y; Department of Nephrology, The Key Laboratory for the Prevention and Treatment of Chronic Kidney Disease of Chongqing, Chongqing Clinical Research Center of Kidney and Urology Diseases, Xinqiao Hospital, Army Medical University (Third Military Medical University), Chongqing, China.
  • Lin Q; Renal Division, Department of Medicine, Peking University Shenzhen Hospital, Shenzhen, Guangdong, China.
  • Hu W; Renal Division, Department of Medicine, Peking University Shenzhen Hospital, Shenzhen, Guangdong, China.
  • Li Y; Renal Division, Department of Medicine, The Third Hospital of Hebei Medical University, Shijiazhuang, Hebei, China.
  • Zheng Z; Renal Division, Department of Medicine, The Third Hospital of Hebei Medical University, Shijiazhuang, Hebei, China.
  • Duan L; Renal Division, Department of Medicine, People's Hospital of Qinghai Province, Xining, Qinghai, China.
  • Fu G; Renal Division, Department of Medicine, People's Hospital of Qinghai Province, Xining, Qinghai, China.
  • Guo S; Renal Division, Department of Medicine, Handan Central Hospital, Handan, Hebei, China.
  • Zhang B; Renal Division, Department of Medicine, Handan Central Hospital, Handan, Hebei, China.
  • Yu R; Renal Division, Department of Medicine, Peking Haidian Hospital, Beijing, China.
  • Hao L; Renal Division, Department of Medicine, Peking Haidian Hospital, Beijing, China.
  • Liu G; Department of Nephrology, Shengjing Hospital of China Medical University, Shenyang , Liaoning, China.
  • Zhao Z; Department of Nephrology, Shengjing Hospital of China Medical University, Shenyang , Liaoning, China.
  • Xiao J; Renal Division, Department of Medicine, The Second Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China.
  • Shen Y; Renal Division, Department of Medicine, The Second Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China.
  • Zhang Y; Renal Division, Department of Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.
  • Du X; Renal Division, Department of Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.
  • Ji T; Renal Division, Department of Medicine, Beijing Miyun District Hospital, Beijing, China.
  • Wang C; Renal Division, Department of Medicine, Beijing Miyun District Hospital, Beijing, China.
  • Deng L; Renal Division, Department of Medicine, The Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, China.
  • Yue Y; Renal Division, Department of Medicine, The Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, China.
  • Chen S; Renal Division, Department of Medicine, The First Affiliated Hospital of BaoTou Medical College, Baotou, Neimenggu, China.
  • Ma Z; Renal Division, Department of Medicine, The First Affiliated Hospital of BaoTou Medical College, Baotou, Neimenggu, China.
  • Li Y; Renal Division, Department of Medicine, People's Hospital of Langfang, Langfang, Hebei, China.
  • Zuo L; Renal Division, Department of Medicine, People's Hospital of Langfang, Langfang, Hebei, China.
  • Zhao H; Renal Division, Department of Medicine, People's Hospital of Gansu, Lanzhou, Gansu, China.
  • Zhang X; Renal Division, Department of Medicine, People's Hospital of Gansu, Lanzhou, Gansu, China.
  • Wang X; Renal Division, Department of Medicine, Peking University People's Hospital, Beijing, China.
  • Liu Y; Renal Division, Department of Medicine, Peking University People's Hospital, Beijing, China.
  • Gao X; Renal Division, Department of Medicine, Pingdingshan First People's Hospital, Pingdingshan, Henan, China.
  • Chen X; Renal Division, Department of Medicine, Pingdingshan First People's Hospital, Pingdingshan, Henan, China.
  • Li H; Renal Division, Department of Medicine, The First People's Hospital of Xining, Xining, Qinghai, China.
  • Du S; Renal Division, Department of Medicine, The First People's Hospital of Xining, Xining, Qinghai, China.
  • Zhao C; Renal Division, Department of Medicine, Taiyuan Central Hospital, Taiyuan, Shanxi, China.
  • Xu Z; Renal Division, Department of Medicine, Taiyuan Central Hospital, Taiyuan, Shanxi, China.
  • Zhang L; Renal Division, Department of Medicine, Cangzhou People's Hospital, Cangzhou, Hebei, China.
  • Chen H; Renal Division, Department of Medicine, Cangzhou People's Hospital, Cangzhou, Hebei, China.
  • Li L; Renal Division, Department of Medicine, First Hospital of Jilin University, Changchun, Jilin, China.
  • Wang L; Renal Division, Department of Medicine, First Hospital of Jilin University, Changchun, Jilin, China.
  • Yan Y; Renal Division, Department of Medicine, The People's Hospital of Chuxiong Yi Autonomous Prefecture, Chuxiong, Yunnan, China.
  • Ma Y; Renal Division, Department of Medicine, The People's Hospital of Chuxiong Yi Autonomous Prefecture, Chuxiong, Yunnan, China.
  • Wei Y; Renal Division, Department of Medicine, The Second Hospital of Shanxi Medical University, Taiyuan, Shanxi, China.
J Nephrol ; 2024 Sep 15.
Article in En | MEDLINE | ID: mdl-39277836
ABSTRACT

BACKGROUND:

Hypokalemia has been associated with an increased risk of peritoneal dialysis (PD)-associated peritonitis. However, hypokalemia is commonly associated with malnutrition, inflammation, and severe coexisting comorbidities, which thus are suspected of being potential confounders. This study was aimed at testing whether hypokalemia was independently associated with the occurrence and prognosis of PD-associated peritonitis.

METHODS:

A national-level dataset from the Peritoneal Dialysis Telemedicine-assisted Platform Cohort (PDTAP) Study was used to explore the independent association of serum potassium with PD-associated peritonitis. Unmatched and propensity score-adjusted multivariate competing risk models, as well as univariate competing risk models following 11 propensity score matching, were conducted to balance potential biases between patients with and without hypokalemia. The association between potassium levels prior to peritonitis and treatment failure due to peritonitis was also investigated.

RESULTS:

During a median follow-up of 25.7 months in 7220 PD patients, there was a higher incidence of peritonitis in patients with serum potassium below 4.0 mmol/L compared to those with higher serum levels (677 [0.114/patient-year] vs. 914 [0.096/patient-year], P = 0.001). After adjusting for demographics, laboratory tests, residual renal function, and medication use, baseline potassium levels below 4.0 mmol/L were not linked to an increased risk of peritonitis, with a hazard ratio of 0.983 (95% CI 0.855-1.130, P = 0.810). This result remained consistent in both the propensity score adjusted multivariate competing risk regression (HR = 0.974, 95% CI 0.829-1.145, P = 0.750) and the univariate competing risk regression after 11 propensity score matching (Fine-Gray test, P = 0.218). The results were similar when analyzing patients with serum potassium level above or below 3.5 mmol/L. Lastly, hypokalemia before the occurrence of peritonitis was not independently associated with treatment failure.

CONCLUSION:

Hypokalemia was not found to be an independent risk factor for PD-associated peritonitis or treatment failure of peritonitis in China.
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: J Nephrol Journal subject: NEFROLOGIA Year: 2024 Document type: Article Affiliation country: China Country of publication: Italy

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: J Nephrol Journal subject: NEFROLOGIA Year: 2024 Document type: Article Affiliation country: China Country of publication: Italy